DK175504B1 - Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf - Google Patents

Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf Download PDF

Info

Publication number
DK175504B1
DK175504B1 DK198700621A DK62187A DK175504B1 DK 175504 B1 DK175504 B1 DK 175504B1 DK 198700621 A DK198700621 A DK 198700621A DK 62187 A DK62187 A DK 62187A DK 175504 B1 DK175504 B1 DK 175504B1
Authority
DK
Denmark
Prior art keywords
oil
pregnanolone
amount
water
final preparation
Prior art date
Application number
DK198700621A
Other languages
Danish (da)
English (en)
Other versions
DK62187A (da
DK62187D0 (da
Inventor
Roland Ingolf Jeppsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of DK62187D0 publication Critical patent/DK62187D0/da
Publication of DK62187A publication Critical patent/DK62187A/da
Application granted granted Critical
Publication of DK175504B1 publication Critical patent/DK175504B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198700621A 1986-02-13 1987-02-06 Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf DK175504B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition
SE8600632 1986-02-13

Publications (3)

Publication Number Publication Date
DK62187D0 DK62187D0 (da) 1987-02-06
DK62187A DK62187A (da) 1987-08-14
DK175504B1 true DK175504B1 (da) 2004-11-15

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700621A DK175504B1 (da) 1986-02-13 1987-02-06 Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf

Country Status (14)

Country Link
US (1) US5028600A (xx)
EP (1) EP0233849B1 (xx)
JP (1) JPH0788305B2 (xx)
AT (1) ATE64526T1 (xx)
CA (1) CA1301651C (xx)
DE (1) DE3770830D1 (xx)
DK (1) DK175504B1 (xx)
ES (1) ES2037742T3 (xx)
FI (1) FI88676C (xx)
GR (1) GR3002299T3 (xx)
HK (1) HK83293A (xx)
NO (1) NO175040B (xx)
SE (1) SE8600632D0 (xx)
SG (1) SG102892G (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
AU2002241738A1 (en) * 2000-12-29 2002-07-16 The Trustees Of Columbia University In The City Of New York Use of iv emulsions with different triglyceride composition, particle size and apolipoprotein e for targeted tissue delivery of hydrophobic compounds
US8182824B2 (en) * 2002-07-02 2012-05-22 Nycomed Gmbh Ciclesonide-containing sterile aqueous suspension
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
KR20070058608A (ko) * 2004-09-13 2007-06-08 바라트 쎄럼스 앤드 백신스 리미티드 항미생물 방부 효능을 갖는 정맥 내 투여를 위한 안정한에멀젼 조성물
CN103491976B (zh) * 2011-01-14 2015-04-01 卡思伯特·O·辛普金斯 用于处理与缺乏血液供给、休克和神经损伤相关的疾病的方法和组合物
US10478505B2 (en) 2011-09-23 2019-11-19 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
RS59734B1 (sr) 2012-01-23 2020-02-28 Sage Therapeutics Inc Formulacije neuroaktivnog steroida koje uključuju kompleks alopregnanolona i sulfobutil etar beta-ciklodekstrina
WO2014028398A2 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
US20140057885A1 (en) 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
US20150313915A1 (en) 2012-11-30 2015-11-05 The Regents Of The University Of California Anticonvulsant activity of steroids
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
RU2766155C2 (ru) 2016-03-08 2022-02-08 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, их композиции и применения
JP2022514991A (ja) * 2018-12-10 2022-02-16 ハロー・サイエンス・エル・エル・シー 安定な麻酔薬製剤および関連する剤形
CA3151334C (en) * 2019-08-19 2024-04-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Topical neurosteroid formulations
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
FI88676C (fi) 1993-06-28
JPH0788305B2 (ja) 1995-09-27
ATE64526T1 (de) 1991-07-15
NO870560D0 (no) 1987-02-12
NO870560L (no) 1987-08-14
SG102892G (en) 1992-12-04
EP0233849A1 (en) 1987-08-26
EP0233849B1 (en) 1991-06-19
US5028600A (en) 1991-07-02
FI870589A0 (fi) 1987-02-12
DK62187A (da) 1987-08-14
HK83293A (en) 1993-08-20
CA1301651C (en) 1992-05-26
JPS62192322A (ja) 1987-08-22
DK62187D0 (da) 1987-02-06
SE8600632D0 (sv) 1986-02-13
NO175040C (xx) 1994-08-24
DE3770830D1 (de) 1991-07-25
NO175040B (no) 1994-05-16
ES2037742T3 (es) 1993-07-01
FI88676B (fi) 1993-03-15
GR3002299T3 (en) 1992-12-30
FI870589A (fi) 1987-08-14

Similar Documents

Publication Publication Date Title
DK175504B1 (da) Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
DE3853191T2 (de) Arzneimittelträger.
KR100410937B1 (ko) 프로포폴을 함유하는 혈관주사용 마취제 조성물
US5651991A (en) Drug carriers
AT408945B (de) Orale pharmazeutische zubereitung
JPH08511245A (ja) 薬剤搬送ビヒクルとしての固体脂肪ナノエマルジョン体
EP2252267A2 (de) Lyophilisierte nanoemulsion
WO2016124162A1 (zh) 一种丙泮尼地药物组合物及其制备方法
JPH02203A (ja) 薬物担体
JPS62270521A (ja) フルルビプロフエン眼投与製剤
DE69525740T2 (de) Spezielle halofantrinhaltige Zusammensetzungen
US6069165A (en) Pharmaceutical compositions containing amisulpride and their therapeutic applications
JP2019510048A (ja) 週1回又は隔週1回の投与に適したリラグルチドの粘弾性ゲル
JPH10510267A (ja) スフィンゴ脂質の投与に適したエマルジョン及びその使用
EP4062904A1 (en) Liquid crystalline structure-forming omega-3-fatty acid composition
JP3074734B2 (ja) 分散製剤
JP2930242B2 (ja) 非経口投与用エマルジヨン
RU2141313C1 (ru) Фармацевтическая эмульсия, содержащая биологически активные стероиды, и способ получения эмульсии
EP0418004B1 (en) Preventive and therapeutic agent for hepatitis
EP0350864B1 (en) Aqueous solution containing fat-soluble vitamin k
JP2022514991A (ja) 安定な麻酔薬製剤および関連する剤形
CN108653204B (zh) 一种多烯磷脂酰胆碱注射液药物组合物及其制备方法
JPH0489430A (ja) 低血圧維持剤
DE3411910A1 (de) Galenische zubereitung

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK